These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 3083548)
21. Avoidance of perioperative renal toxicity by a modified immunosuppression protocol. Kormos RL; Trento A; Hardesty RL; Griffith BP; Thompson M; Bahnson HT Transplant Proc; 1987 Feb; 19(1 Pt 3):2525-6. PubMed ID: 3274555 [No Abstract] [Full Text] [Related]
22. Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results. van Wezel HB; Hilbrands LB; Koene RA; Hoitsma AJ Transplant Proc; 1994 Oct; 26(5):2550-2. PubMed ID: 7940787 [No Abstract] [Full Text] [Related]
23. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function. Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814 [No Abstract] [Full Text] [Related]
24. Triple low-dose immunosuppression with cessation of steroids in pediatric renal transplantation. Walker RG; d'Apice AJ; Powell HR; Francis DM; Kincaid-Smith P Transplant Proc; 1988 Feb; 20(1):7-10. PubMed ID: 3278465 [No Abstract] [Full Text] [Related]
25. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients. Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904 [No Abstract] [Full Text] [Related]
26. A retrospective analysis of long-term renal allograft function associated with cyclosporine-prednisone immunosuppressive therapy. Lewis RM; Janney RP; Van Buren CT; Kerman RH; Herson J; Kerr NA; Golden DA; Kahan BD Transplant Proc; 1988 Jun; 20(3 Suppl 3):534-9. PubMed ID: 3291291 [No Abstract] [Full Text] [Related]
27. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation. Fries D; Hiesse C; Santelli G; Gardin JP; Cantarovich M; Lantz O; Charpentier B; Paillard M; Benoit G Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226 [No Abstract] [Full Text] [Related]
28. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients. Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453 [No Abstract] [Full Text] [Related]
29. The long-term results of thoracic duct drainage in living related kidney transplantation. Ohshima S; Ono Y; Kinukawa T; Matsuura O; Takeuchi N; Hattori R Transplant Proc; 1989 Feb; 21(1 Pt 2):1972-3. PubMed ID: 2652644 [No Abstract] [Full Text] [Related]
30. Long-term cyclosporine for renal allograft patients does not cause nephrotoxicity. Post GR; Moyer TP; Anderson CF; Sterioff S Transplant Proc; 1987 Feb; 19(1 Pt 2):1761-3. PubMed ID: 3079036 [No Abstract] [Full Text] [Related]
31. Dallas experience with cyclosporine A (CsA) one to six months posttransplant. Hull AR; Atkins CR; Brinker KR; Dawidson I; Dickerman RM; Emerson W; Helderman JH; Levitz B; Long DL; Nesser D Transplant Proc; 1986 Apr; 18(2 Suppl 1):128-31. PubMed ID: 3515679 [No Abstract] [Full Text] [Related]
37. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine. Kliem V; Repp H; Frei U Transplant Proc; 1994 Oct; 26(5):2553-5. PubMed ID: 7940788 [No Abstract] [Full Text] [Related]